Rosen Law Firm is investigating potential securities claims against PennyMac Financial Services following allegations that the company issued misleading financial information. PennyMac reported a sharp decline in its servicing segment income for Q4 2025, causing its stock to fall 33.3% on January 30, 2026. Investors who purchased PennyMac securities may be eligible for compensation through a class action lawsuit being prepared by Rosen Law Firm. The firm encourages affected investors to join the case for potential recovery of losses without upfront fees.
PennyMac Financial Services is noted here with a focus on the Financials sector, where 16 of 85 US stocks traded on Pluang rose and 69 fell as of Oct 08, 2026 01:21 WIB. Among notable movers, Bit Digital Inc (BTBT) traded at USD 1.46 with a 1-day change of -3.95% and a typical hold time of 13 days, while Hut 8 Corp (HUT) was priced at USD 88.75, down 3.76%, with a 90% sell order activity. Toronto-Dominion Bank (TD) stood at USD 114.24, down 3.33%, with a typical hold time of 84 days and 100% buy order activity on Pluang.
Thailand's textile market is projected to grow from USD 4.97 billion in 2026 to USD 5.39 billion by 2032, at a CAGR of 1.31%. Growth is fueled by domestic fiber production, machinery upgrades, and rising demand for faster garment replenishment, espec...
A SEON survey of 2,026 U.S. adults reveals that while 68% use AI agents weekly for personal tasks, half are uncomfortable letting AI handle credit card purchases. Only 15% would share financial info with AI, and 43% lack confidence in spotting fraudu...
Callan JMB has received and will install a QuickStrip™ oral thin-film production line from Rapid Dose Therapeutics at its Texas facility, marking a key step in expanding its domestic pharmaceutical manufacturing. This new capability aims to produce f...
Known, a company developing accountability infrastructure for autonomous AI, announced that Edna Conway, former senior security executive at Microsoft and Cisco, has joined its Advisory Council. Conway brings extensive experience in cybersecurity and...
Radiopharm Theranostics announced progress in its oncology radiopharmaceutical pipeline, including preparing for a pivotal Phase 3 imaging trial of RAD101 for recurrent brain metastases after a successful FDA End-of-Phase 2 meeting. The company also ...
